How many insider trades does FilingIQ track for BRNS?

FilingIQ tracks 11 Form 4 insider transactions for BRNS (Barinthus Biotherapeutics plc.), covering filings from Sep 9, 2026 onwards. 11 of those are dated within the last 90 days.

Are BRNS insiders net buyers or net sellers?

Across the full Form 4 history for BRNS, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does BRNS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

What sector is BRNS in?

Barinthus Biotherapeutics plc. (BRNS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $30.23M.

BRNS insider trading

NasdaqCM Healthcare

Barinthus Biotherapeutics plc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$30.23M

About Barinthus Biotherapeutics plc.

Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to restore immune non-responsiveness to gluten in patients with celiac disease; and VTP-300, an immunotherapy, which is in Phase II clinical trial for the treatment of chronic hepatitis B virus infection. It has a license agreement with Oxford University Innovation for the development and commercialization of products with thermo-responsive adjuvant scaffolds; and U.S. National Institutes of Health for the evaluation of synthetic and polymer-based vaccine technology to prevent infectious disease and treat cancer in animal models. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is based in Germantown, Maryland.

Company website: www.barinthusbio.com

BRNS insider activity at a glance

FilingIQ tracks 11 insider transactions for BRNS in filings since Sep 9, 2026. The most recent transaction is dated Sep 9, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

View live BRNS trades on FilingIQ Raw filings on SEC EDGAR

Latest BRNS Form 4 filings

Oxford Science Enterprises plc

Hooftman Leon Chief Medical Officer

AD Sep 9, 2026

Hammacher Alex

D Sep 9, 2026

Enright William Chief Executive Officer

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

UTHR 865

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

ATTO 123

Attovia Therapeutics, Inc.

TEM 104

Tempus AI, Inc.

CORT 103

CORCEPT THERAPEUTICS INC

CSTL 100

CASTLE BIOSCIENCES INC

Frequently asked

How many insider trades does FilingIQ track for BRNS?: FilingIQ tracks 11 Form 4 insider transactions for BRNS (Barinthus Biotherapeutics plc.), covering filings from Sep 9, 2026 onwards. 11 of those are dated within the last 90 days.
Are BRNS insiders net buyers or net sellers?: Across the full Form 4 history for BRNS, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BRNS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is BRNS in?: Barinthus Biotherapeutics plc. (BRNS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $30.23M.

Methodology & sources

Every BRNS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.